Steward Partners Investment Advisory’s Syndax Pharmaceuticals SNDX Stock Holding History

Steward Partners Investment Advisory’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.73K	Hold	331	–	–	﹤0.01%	3651
2025 Q4	$6.95K	Buy	331 +100	+43%	+$1.75K	﹤0.01%	3587
2025 Q3	$3.55K	Hold	231	–	–	﹤0.01%	3757
2025 Q2	$2.16K	Hold	231	–	–	﹤0.01%	3711
2025 Q1	$2.84K	Hold	231	–	–	﹤0.01%	3559
2024 Q4	$3.05K	Hold	231	–	–	﹤0.01%	3516
2024 Q3	$4.45K	Hold	231	–	–	﹤0.01%	3224
2024 Q2	$4.74K	Hold	231	–	–	﹤0.01%	3061
2024 Q1	$5.5K	Hold	231	–	–	﹤0.01%	3014
2023 Q4	$4.99K	Buy	+231	New	+$3.55K	﹤0.01%	2959

Other funds holding SNDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Steward Partners Investment Advisory's SNDX Position: Q1 2026 in Review

Steward Partners Investment Advisory held its Syndax Pharmaceuticals (SNDX) position steady in Q1 2026 at 331 shares worth $7.73K. The position accounts for ﹤0.01% of the portfolio, ranked #3651.

Steward Partners Investment Advisory first reported a position in SNDX in Q4 2023 and has held it in 10 quarters since. 246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

Steward Partners Investment Advisory held 331 shares of Syndax Pharmaceuticals worth $7.73K as of Q1 2026.
Steward Partners Investment Advisory left its Syndax Pharmaceuticals share count unchanged in Q1 2026.
Syndax Pharmaceuticals made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #3651 holding.
Steward Partners Investment Advisory first reported a position in Syndax Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.